Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | MI-503 |
Trade Name | |
Synonyms | MI 503|MI 503 |
Drug Descriptions |
MI-503 inhibits the interaction between Menin and MLL (KMT2A), potentially leads to inhibition of growth and migration of tumor cells (PMID: 25817203, PMID: 29142068). |
DrugClasses | MEN1-KMT2A Inhibitor 5 |
CAS Registry Number | 1857417-13-0 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Enzalutamide + MI-503 | Enzalutamide MI-503 | 0 | 0 |
MI-503 | MI-503 | 6 | 0 |
MI-503 + Sorafenib | MI-503 Sorafenib | 0 | 0 |